Bramah N. Singh (3 March 1938 – 20 September 2014) was a cardiac pharmacologist and academic.[1][2][3]
Early life and education
Born in Fiji, he graduated in medicine from
University of Otago (New Zealand) in 1963 and completed residency at
Auckland Hospital, followed by a cardiology fellowship at
Green Lane Hospital. In 1969, Singh was awarded a Nuffield travelling fellowship and moved to Oxford to work with
Miles Vaughan Williams. There, he worked on the anti-arrhythmic properties of drugs including
amiodarone.[4][5] Such work helped to refine the characteristics of Class III compounds in the developing
Vaughan Williams classification.[6]
Career
Some reviews on antidysrhythmic drugs during his lifetime credited his work in developing the classification system equally with Vaughan Williams, leading to the classification sometimes being called the Singh Vaughan Williams classification.[7][8][9]
^Nattel, S (26 November 1993). "Comparative mechanisms of action of antiarrhythmic drugs". The American Journal of Cardiology. 72 (16): 13F–17F.
doi:
10.1016/0002-9149(93)90959-G.
PMID8237825.
^Kowey, PR; Marinchak, RA; Rials, SJ; Bharucha, D (23 October 1997). "Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs". The American Journal of Cardiology. 80 (8A): 16G–23G.
doi:
10.1016/S0002-9149(97)00710-8.
PMID9354408.